Not Yet RecruitingNot Applicable

Metacognitive Therapy Compared to Cognitive-behavioral Therapy

30 participantsStarted 2026-02

Plain-language summary

This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years or older, * A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder, * No change in dose during the last six weeks if on pharmacological treatment, and * Ability to read and speak Swedish. Exclusion Criteria: * A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder, * Acute suicide risk, or * Concurrent psychological treatment.

What they're measuring

Qualitative interview data

Timeframe: Up to 13 weeks

Trial details

NCT IDNCT07382323

SponsorKarolinska Institutet

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

Contact for this trial

Benjamin Bohman

0701713443 benjamin.bohman@ki.se

View on ClinicalTrials.gov More Generalized Anxiety Disorder trials